Korean J Radiol.  2018 Oct;19(5):866-871. 10.3348/kjr.2018.19.5.866.

2018 Korean Clinical Imaging Guideline for Hemoptysis

• Kang MJ
• Kim JH
• Kim YK
• Lee HJ
• Shin KM
• Kim JI
• Lee HJ
• Do KH
• Yong HS
• Choi SJ
• Choi M
• Jung JI

• KMID: 2418549
• DOI: http://doi.org/10.3348/kjr.2018.19.5.866

Abstract

In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.

Keyword

Guideline; Hemoptysis; Thorax; Lung; Radiography; X-ray; Computed tomography; Evidence; Republic of Korea

MeSH Terms

Adult
Advisory Committees
Consensus
Hemoptysis*
Humans
Korea
Lung
Lung Neoplasms
Pulmonary Fibrosis
Radiography
Republic of Korea
Risk Factors
Smoke
Smoking
Thorax
Tomography, X-Ray Computed
Tuberculosis
Smoke

Figure

• 

  Fig. 1 Flow chart for literature selection.GIN = Guideline International Network, KCIG = Korean Clinical Imaging Guidelines, KGC = Korean Guideline Clearinghouse, KoMGI = Korean Medical Guidelines and Information, NGC = National Guideline Clearinghouse

Reference

1. ACR Appropriateness Criteria®. Hemoptysis. American College of Radiology Web site. Accessed January 31, 2017. https://acsearch.acr.org/docs/69449/Narrative/. Published August, 2010.

2. Choi SJ, Jeong WK, Jo AJ, Choi JA, Kim MJ, Lee M, et al. Methodology for developing evidence-based clinical imaging guidelines: joint recommendations by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J Radiol. 2017; 18:208–216. PMID: 28096730.

3. Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration. 2006; 73:808–814. PMID: 16446530.

4. Fidan A, Ozdoğan S, Oruç O, Salepçi B, Ocal Z, Cağlayan B. Hemoptysis: a retrospective analysis of 108 cases. Respir Med. 2002; 96:677–680. PMID: 12243312.

5. Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J. Multi-detector row CT of hemoptysis. Radiographics. 2006; 26:3–22. PMID: 16418239.

6. Lee SJ, Rho JY, Yoo SM, Kim MD, Lee JH, Kim EK, et al. Usefulness of multi-detector computed tomography before bronchoscopy and/or bronchial arterial embolization for hemoptysis. Tuberc Respir Dis. 2010; 68:80–86.

7. Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002; 179:1217–1224. PMID: 12388502.

8. Delage A, Tillie-Leblond I, Cavestri B, Wallaert B, Marquette CH. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration. 2010; 80:387–392. PMID: 19996573.

9. Menchini L, Remy-Jardin M, Faivre JB, Copin MC, Ramon P, Matran R, et al. Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients. Eur Respir J. 2009; 34:1031–1039. PMID: 19357153.

10. Poe RH, Israel RH, Marin MG, Ortiz CR, Dale RC, Wahl GW, et al. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Chest. 1988; 93:70–75. PMID: 3335170.

11. Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest. 2001; 120:1592–1594. PMID: 11713139.

12. Thirumaran M, Sundar R, Sutcliffe IM, Currie DC. Is investigation of patients with haemoptysis and normal chest radiograph justified? Thorax. 2009; 64:854–856. PMID: 19457872.

13. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest. 1994; 105:1155–1162. PMID: 8162743.

14. Kim HB. Bronchial artery embolization. Korean Society of Interventional Radiology. Interventional radiology. 2nd ed. Seoul: Ilchokak;2014. p. 321–325.

15. Millar AB, Boothroyd AE, Edwards D, Hetzel MR. The role of computed tomography (CT) in the investigation of unexplained haemoptysis. Respir Med. 1992; 86:39–44. PMID: 1565816.

16. Khalil A, Fartoukh M, Parrot A, Bazelly B, Marsault C, Carette MF. Impact of MDCT angiography on the management of patients with hemoptysis. AJR Am J Roentgenol. 2010; 195:772–778. PMID: 20729459.

17. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 2001; 177:861–867. PMID: 11566690.